Table 3.
Average laboratory parameters before and after remdesivir therapy
| Parameter | At the time of admission | On the 3rd day of remdesivir therapy | Two-tailed P |
|---|---|---|---|
| Liver function tests | |||
| ALT (IU) | 43.04±30.89 | 71.21±70.23 | <0.001 |
| AST (IU) | 46.6±20.16 | 50.78±38.8 | 0.9672 |
| ALP (IU) | 80±31.19 | 100.4±118.54 | 0.2522 |
| Albumin (mg/dL) | 3.58±0.44 | 3.45±0.45 | 0.0029 |
| Globulin (mg/dL) | 3.41±0.47 | 3.44±0.30 | >0.999 |
| Total protein (mg/dL) | 6.84±0.52 | 6.89±0.47 | 0.1327 |
| Total bilirubin (mg/dL) | 0.87±0.49 | 0.59±0.18 | <0.001 |
| Renal function tests | |||
| Serum creatinine (mg/dL) | 0.82±0.20 | 0.70±0.11 | <0.001 |
| Blood urea (mg/dL) | 39.64±17.90 | 41.82±12.90 | 0.0089 |
| WBC count | 5631±3089 | 5962±3610 | 0.189 |
| Platelet count | 2.37±0.60 | 2.54±0.65 | <0.001 |
| Random blood sugars (RBS) mg/dL | 177.12±91.86 | 226.26±87.15 | 0.0071 |
P<0.05 significant